GERN—Wish Dew would consider this company’s work as a candidate for the RMF section.
You don’t need my approval to create a ReadMeFirst primer for GERN or any other biotech company. All you have to do is organize a set of links to the most pertinent information on the company and the stock, and keep the file up to date by revising it every now and then. That’s it!
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”